COP
44
-3
PNW
57
2
CPB
37
2
PEG
50
4
SJM
14
3
AAPL
55
2
ALLE
48
2
EQT
51
-5
TROW
61
2
MHK
50
2
VLO
40
-2
PSA
37
2
SO
53
5
NEM
69
-2
VTR
70
3
ES
50
3
HRL
38
3
A
46
2
FITB
72
2
PHM
43
2
COP
44
-3
PNW
57
2
CPB
37
2
PEG
50
4
SJM
14
3
AAPL
55
2
ALLE
48
2
EQT
51
-5
TROW
61
2
MHK
50
2
VLO
40
-2
PSA
37
2
SO
53
5
NEM
69
-2
VTR
70
3
ES
50
3
HRL
38
3
A
46
2
FITB
72
2
PHM
43
2
Financhill
Back

The Goldman Sachs Group, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
78

GS
The Goldman Sachs Group, Inc.

Last Price:
$906.97
Seasonality Move:
4.62%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Buy
78
The Goldman Sachs Group, Inc. (GS) is a Buy

Is The Goldman Sachs Group, Inc. a Buy, Sell or Hold?

  • The current The Goldman Sachs Group, Inc. [GS] share price is $910.78. The Score for GS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • GS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GS Stock Price Chart

What is The Goldman Sachs Group, Inc.'s stock price today?

  • The The Goldman Sachs Group, Inc. share price today is $910.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GS is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

GS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 25.62 Buy
Relative Strength Index (14 RSI): 69.82 Buy
Chaikin Money Flow: 642955 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (807.19 - 895.03) Buy
Bollinger Bands (100): (741.15 - 838.09) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

GS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 890.29 Buy
20-day SMA: 867.55 Buy
50-day SMA: 816.78 Buy
200-day SMA: 698.94 Buy
8-day EMA: 892.99 Buy
20-day EMA: 869.15 Buy
50-day EMA: 831 Buy
200-day EMA: 726.08 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

The Goldman Sachs Group, Inc. Earnings Growth & GS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.67 per share, and an increase next year of $6.39 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

The Goldman Sachs Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):